Publications

Betz B, Büchner T, Kiehntopf M.; Effect of the Method for Creatinine Measurement; Dtsch Arztebl Int. 2017 Apr 28;114(17):300. doi: 10.3238/arztebl.2017.0300b
Betz BB, Jenks SJ, Cronshaw AD, et al. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes. Kidney Int 2016; 89: 1125-1135.
Betz B, Conway BR. An Update on the Use of Animal Models in Diabetic Nephropathy Research. Curr Diab Rep 2016; 16: 18., Review
Schneider R, Meusel M, Betz B, et al. Oat1/3 restoration protects against renal damage after ischemic AKI. Am J Physiol Renal Physiol 2015; 308: F198-208.
Conway BR, Betz B, Sheldrake TA, et al. Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosis. Nephrology (Carlton) 2014; 19: 802-813.
Betz B, Conway BR. Recent advances in animal models of diabetic nephropathy. Nephron Exp Nephrol 2014; 126: 191-195., Review
Betz B, Moller-Ehrlich K, Kress T, et al. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Transl Res 2013; 162: 67-76.
Betz B, Schneider R, Kress T, et al. Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury. PPAR Res 2012; 2012: 219319.
Schneider R, Meusel M, Betz B, et al. Nitric oxide-induced regulation of renal organic cation transport after renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 2011; 301: F997-F1004.
Schneider R, Sauvant C, Betz B, et al. Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 2007; 292: F1599-1605.